Cargando…
Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer
BACKGROUND: The expression of novel oncogenic kinase (NOK), a member of the protein tyrosine kinase (PTK) family, has been observed in several human malignancies including non-small cell lung cancer (NSCLC). However, the clinic relevance of NOK expression in NSCLC remains unclear. METHODS: In this s...
Autores principales: | Chen, Peng, Li, Wei-Miao, Lu, Qiang, Wang, Jian, Yan, Xiao-Long, Zhang, Zhi-Pei, Li, Xiao-Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051150/ https://www.ncbi.nlm.nih.gov/pubmed/24894011 http://dx.doi.org/10.1186/1471-2407-14-402 |
Ejemplares similares
-
Aberrantly High Expression Of NOK/STYK1 Is Tightly Associated With The Activation Of The AKT/GSK3β/N-Cadherin Pathway In Non-Small Cell Lung Cancer
por: Huang, Zhao, et al.
Publicado: (2019) -
STYK1/NOK Promotes Metastasis and Epithelial-Mesenchymal Transition in Non-small Cell Lung Cancer by Suppressing FoxO1 Signaling
por: Lai, Yuanyang, et al.
Publicado: (2021) -
Downregulation of GLUT3 impairs STYK1/NOK-mediated metabolic reprogramming and proliferation in NIH-3T3 cells
por: Shi, Weiye, et al.
Publicado: (2021) -
STYK1/NOK affects cell cycle late mitosis and directly interacts with anaphase-promoting complex activator CDH1
por: Zeng, Su-Lin, et al.
Publicado: (2022) -
TERT Mutations in Non–Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Implications
por: Yang, Liu, et al.
Publicado: (2023)